Xtant Medical Holdings, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for XTNT, updated each market day.
XTNT AI Sentiment
AI sees no strong directional signal for Xtant Medical Holdings, Inc. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Sector
Exchange
Market Cap
$66,504,409
Cap Tier
Employees
151
Headquarters
BELGRADE, MT
Listed Since
Jan. 31, 2007
Website
XTNT Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
XTNT Volatility
Xtant Medical Holdings, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
